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Introduction: Determining the cause of spontaneous (non-traumatic) intracerebral 
haemorrhage (ICH) is critical to guide treatment and prognosis. We investigated whether 
small vessel disease (SVD) in addition to clinical and other radiological findings on acute 
neuroimaging predicts a low risk of a macrovascular cause (e.g. an arterio-venous 
malformation, aneurysm, or dural arteriovenous fistula). 
Patients and Methods: We identified patients with acute spontaneous ICH who underwent 
acute non-contrast CT, CT angiography (CTA) and intra-arterial digital subtraction 
angiography (IADSA) at our institution from January 2010-April 2014. Logistic regression 
including CTA result, SVD, age, pre-ICH hypertension and ICH location was used to derive 
a prediction model, validated using bootstrapping. 
Results: 173 patients (46% female, median age 49) of whom 78 had a macrovascular cause 
on IADSA were included. Predictors of a macrovascular cause were: abnormal CTA (OR 
67.4; p<0.001); absence of SVD (OR 5.0; p=0.019); and absence of pre-ICH hypertension 
(OR 3.4; p=0.05). In our internally-derived prediction model, the combination of CTA, SVD 
and pre-ICH hypertension predicted the likelihood of an underlying macrovascular cause 
(optimism-adjusted ROC area 0.919). Patients with negative CTA, SVD and pre-ICH 
hypertension have a low likelihood of an underlying macrovascular cause (1.8%). 
Discussion and Conclusion: A combination of CTA, SVD and pre-ICH hypertension predict 
the likelihood of finding a macrovascular cause in patients with acute spontaneous ICH, 











Intracerebral haemorrhage (ICH) is devastating: mortality is 54% at 1 year (1), while only 12-
39% of survivors recover to independence (2). Most cases (77–88%) of spontaneous (non-
traumatic) intracerebral haemorrhage are termed “primary” (3), with a presumption that they 
are caused by small vessel disease (SVD) (4). However, it is critical to exclude “secondary” 
structural causes of ICH, including macrovascular causes (e.g. arterio-venous malformations, 
aneurysms, and dural arteriovenous fistulae), which can be treated.  
The “reference standard” for detection of a macrovascular cause is intra-arterial digital 
subtraction angiography (IADSA) or neurosurgery. IADSA is invasive, requires skilled 
operators and is associated with a small but appreciable mortality and morbidity, especially in 
acute ICH (5). Selecting which ICH patients have a sufficiently high likelihood of a 
macrovascular cause to recommend IADSA is a common and important clinical question. 
Current practice varies widely (6): typically, the presence of pre-ICH hypertension, deep 
location of ICH and age are used as indicators of SVD to select patients unlikely to require 
IADSA(6), but the evidence supporting this is scant and often conflicting (7-9). A scoring 
system developed in Boston incorporating pre-ICH hypertension and age (among other 
factors) to identify patients at risk of a macrovascular cause has been previously validated, 
but did not include imaging markers of SVD and only had moderate discrimination outside of 
the United States. (10, 11). SVD can be directly identified on brain imaging by leukoaraoisis 
and lacunar infarction, even on plain CT. We therefore hypothesised that, in acute ICH 
patients, visualization of SVD will predict a low yield of a macrovascular cause; furthermore, 
we aimed to develop and internally validate an algorithm to help clinicians identify patients at 




Patient and methods  
Patient selection 
We retrospectively reviewed all consecutive patients who underwent IADSA (the reference 
standard for detecting a macrovascular cause of ICH) for the investigation of ICH from 
January 2010-April 2014. Inclusion criteria were: acute, symptomatic, non-traumatic 
(spontaneous) ICH, with availability of diagnostic quality CTA, non-contrast CT and an 
IADSA. Patients with a primary diagnosis of subarachnoid haemorrhage (SAH) or subdural 
haemorrhage were excluded. In our centre, all patients presenting to our stroke unit with 
acute ICH have acute non-contrast CT and CTA unless there is a contra-indication. The need 
for an IADSA is decided during a weekly multidisciplinary vascular neuroradiological 
meeting where the patient’s age, ICH location and history (including hypertension) are taken 
into account, as per standard clinical practice. We did not exclude patients on the basis of 
age. We recorded whether the patient had a suspicion of a macrovascular cause on the non-
invasive imaging prior to the IADSA to explore partial verification bias.  
Data collection 
Variables collected were: age (dichotimised into aged 45 years or over vs. under 45, in 
keeping with current clinical practice and previous studies (8, 12)); pre ICH hypertension 
(defined by previously documented HTN for which either lifestyle advice or antihypertensive 
medication had been provided); and location of the ICH (cerebellar, intraventricular (pure), 
lobar and deep perforator territory (brainstem and basal ganglia)). 
Image analysis 
A trained vascular neuroradiology fellow (AO) reviewed the acute CTA, blinded to the 
IADSA result, for the presence of any structural macrovascular cause. This CTA evaluation 
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was then compared to the final clinical report (by an accredited consultant vascular 
neuroradiologist). Disagreement was reviewed by a professor of vascular neuroradiology 
(HRJ) and a consensus decision was reached. A “negative” CTA was defined as showing no 
indication of a macrovascular cause. A “positive” CTA was defined by the final 
neuroradiology assessment as being suspicious for a macrovascular cause (graded as either 
having a “possible” or “definite” underlying macrovascular cause). A clinical research fellow 
(DW) trained in SVD rating rated the non-contrast CT for SVD using the simplified Fazekas 
scale (13) and the presence of lacunae, blinded to the IADSA result. SVD on CT was 
dichotomised into moderate-severe (Fazekas grade ≥2 in either periventricular or deep white 
matter distribution) and/or the presence of any lacunar infarction vs. mild/none SVD and no 
lacunar infarctions. SVD was rated in the hemisphere contralateral to the symptomatic ICH to 
avoid misclassification of peri-haematomal oedema. Haematoma location was classified 
using a recently published rating instrument (14) . The IADSA was reported by a certified 
consultant vascular neuroradiologist. The routine IADSA protocol for investigation of 
intracerebral haemorrhage at our institution includes selective catheterisation of the internal 
carotid, external carotid and vertebral arteries, with angiographic runs of each of these vessels 
in at least two projections and followed through to the venous phase. 
Statistical analysis 
Univariable odds ratios and the sensitivity and specificity (presented as ROC area under the 
curve) were undertaken for the following variables: age, ICH location, HTN, CTA result and 
SVD identification on CT against the reference standard of IADSA detected macrovascular 
causes. 
We fitted a logistic regression model to generate risk coefficients for macrovascular causes. 
We checked the fit of the model by comparing the models prediction to the observed 
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outcomes. This model was then internally validated using bootstrap validation with 1000 
samples. Discrimination was quantified using the ROC area and calibration was assessed 
using the Cox-Miller calibration slope. 
All analyses were performed using STATA 12.0 (StataCorp LP, TX). 




The study was approved by the Clinical Governance Committee of the National Hospital and 
the UCL Institute of Neurology and National Hospital Joint Research Ethics Committee.  
Results 
We identified 204 patients with acute spontaneous ICH who had an IADSA. The median age 
was 49 (range 18 – 86, IQR 40 to 59)) and 54% were males. After quality assurance, we 
included 173 patients with diagnostic quality CTA in the study (Figure 1). Within this group 
there were 78 IADSA-defined macrovascular causes (68 AVMs, 7 dural fistulas, 2 aneurysms 
and 1 carotid-cavernous fistula). The median CTA to IADSA time was 2 days (IQR 1 to 11). 
3 vascular malformations were only detected on repeat IADSA; of these patients the median 
CT-repeat DSA was 264 days (IQR 78 to 314). ICH locations in the final cohort were: lobar 
83, deep perforator territory 60 (basal ganglia, thalamus, caudate, brainstem), Cerebellar 21, 




CTA identified 85 cases with a definite or possible macrovascular cause. 67/67 cases 
identified as “definite” vascular abnormalities on CTA were identified as true macrovascular 
causes on IADSA. 11/18 cases identified as “possible” macrovascular causes on CTA were 
identified as true macrovascular causes on IADSA. In 17 instances there was discordance 
between the trained vascular neuroradiology fellow and the clinical report; 11 of these were 
judged to have a possible macrovascular cause by consensus adjudication with the professor 
of vascular neuroradiology (HRJ). 
In univariable analysis a positive CTA (“definite” or “possible” suspicion for a 
macrovascular cause) has the highest odds ratio for detecting a macrovascular cause (and the 
greatest area under the curve), followed by: non-deep perforator ICH location; the absence of 
SVD; the absence of pre-ICH hypertension; and age less than 45 years. (Table 2).  
We fitted a logistic regression model to the five predictors (with ICH location simplified to 
non-deep perforator ICH location vs. deep perforator ICH location) to develop a model to 
predict the risk of a macrovascular cause. Abnormal CTA was the most important predictive 
factor of the presence of a macrovascular cause in the model (OR 67.4; 95% CI 21.3 to 213.1 
p<0.001), followed by absence of SVD (OR 5.0; 95% CI 1.3 to 19.6 p=0.019); and absence 
of pre-ICH hypertension (OR 3.4; 95% CI 1.0 to 11.4 p=0.05). The two weakest predictors -
ICH location (OR 2.8; 95% CI 0.96 to 8.5 p=0.060) and age <45y (OR 1.1; 95% CI 0.4 to 3.1 
p=0.90) - were then omitted, which had little impact on the model fit. This simplified model 
contains just 3 binary predictors (regression coefficients and model intercept: CTA positive 
4.7, No SVD 1.5, No pre stroke hypertension 1.3, intercept -4.0), and thus can make 8 unique 
predictions. which showed excellent agreement with the actual patient IADSA findings 
(Hosmer-Lemeshow goodness of fit p=0.99; no evidence of lack of fit) (Table 3). Bootstrap 
validation reveals that the ‘optimism-adjusted’ (15) ROC area for the simplified model is 
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0.919 (Figure 2) and that the Cox-Miller calibration (15) slope is 0.949 which suggests that 
the risk model is well calibrated.  
The final model allowed us to estimate the risk of a macrovascular cause for any patient 
based on the combination of CTA result, pre-ICH hypertension and SVD on CT. (Table 3). 
The predicted yield of a macrovascular cause for each combination of predictors is also 
presented in an algorithm (Figure 3).  
Discussion 
In a population of acute ICH patients at risk of an underlying macrovascular cause (having 
had IADSA based on age, ICH location and vascular risk factors), the presence of small 
vessel disease (confluent leukoaraiosis and/or one or more lacunes) on non-contrast CT is a 
useful predictor of the likelihood of finding an underlying macrovascular cause. In our 
internally validated model, an abnormal CTA, or the combination of a normal CTA with no 
evidence of SVD (confluent leukoaraiosis on CT) indicate an intermediate to high yield of an 
underlying macrovascular cause, which might justify undertaking IADSA. 
If externally validated on a prospective cohort, the use of our algorithm in clinical practice 
could lead to more macrovascular causes being detected (higher sensitivity) with an 
acceptable level of non-diagnostic IADSAs. For instance, if we used our algorithm on our 
own sample, choosing  a predicted yield for a macrovascular cause of >5% as an indication 
for IADSA, our algorithm would yield 12 more macrovascular causes compared to using 
CTA alone, at the expense of 85 more negative IADSAs (i.e. an extra 7 patients undertaking 
an IADSA per additional macrovascular cause identified). In practice, clinicians must balance 
the expected yield of the IADSA against the procedural risk. 
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The sensitivity of acutely performed CTA for identifying a macrovascular cause in our study 
(82%) is lower than reported in a recent meta-analysis of 95% (CI 90-97%) (16), likely due to 
our use of repeat or delayed IADSA, which revealed a macrovascular cause not seen on the 
acute IADSA in 3 instances. Delayed IADSAs were not undertaken in studies involved in the 
above meta-analysis. Previous studies compared only acute CTA to acute IADSA. However, 
a recent multicentre prospective study also found a lower sensitivity of acute CTA, in line 
with our findings (17).  The difference is consistent with an additional yield of macrovascular 
causes from delayed IADSA, a well recognized observation in clinical practice, which could 
be in part related to acute haemorrhage and perihaematomal oedema obscuring small 
macrovascular lesions. Our study was not able to investigate whether delayed CTA has 
similar diagnostic accuracy to delayed IADSA, which is a topic for further research.  
Although a small case series has previously shown the added diagnostic value of MRI when 
IADSA is inconclusive (18), we are only aware of one other study that specifically tests 
direct visualization of small vessel disease to improve the prediction of the likelihood of an 
underlying vascular malformation (17). In keeping with this study (17), our data suggests the 
presence of SVD on acute CT (when CTA is not suspicious for a macrovascular cause) is a 
useful predictor of a low yield of an underlying macrovascular cause in the investigation of 
younger patients with spontaneous ICH  (mean ages 53 years in the previous study (17) and 
50 years in the current study).  
Importantly, in our study 3 patients with an underlying macrovascular cause were older than 
45 years with known hypertension and a cerebellar ICH. This combination of variables has 
previously been associated with a 0% yield of macrovascular causes (8), but our data indicate 




Our study has important strengths. All patients identified with a suspected macrovascular 
cause for ICH at our centre undergo IADSA, so our initial search captured all patients 
diagnosed with a known macrovascular cause over the study period. Most patients had acute 
CTA on admission using a standardised care pathway, reducing the potential for selection 
bias. Our centre has a low threshold for requesting IADSA in suspected macrovascular causes 
and we were therefore able to include a large cohort of patients with CTA, CT and IADSA 
(n=173), which compares favourably in size to previous studies (12, 19-22). The time interval 
between CTA and the initial DSA was very short, and we included independent blinded CTA 
ratings by vascular neuroradiologists. Furthermore we performed delayed and multiple 
IADSAs in selected patients, which increased the detection of macrovascular causes. 
Nevertheless our study also has limitations. The retrospective nature of the study is likely to 
cause selection and partial verification bias. Although 63% of our cohort had a normal initial 
CTA (suggesting that there is little partial verification or “work up” bias), our sample is 
younger than an unselected ICH cohort (median age 48, IQR 40-48), suggesting selection 
bias, likely due to the fact that IADSA was an inclusion criterion. This reflects current 
clinical practice with an inherent hesitancy for requesting IADSA in older individuals (e.g. > 
70 years) in whom that the yield of a macrovascular cause is perceived to be very low (8).  
This selection bias toward younger individuals also explains why our proportion of vascular 
malformations is much higher than one would expect from an unselected population. Our 
results can thus only be generalized to younger patients with ICH. This is a difficult bias to 
overcome in any study, because undertaking IADSA in all unselected consecutive patients 
with ICH is unlikely to be considered ethical because of the procedural risk, which may be as 
high as 3% in ICH (5). Nevertheless, this acknowledged selection bias is unlikely to weaken 
our main finding that SVD is predictive of a low yield of a macrovascular abnormality. 
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We did not capture ICH volume in our cohort, which would have been useful to better 
characterise our population. In particular the proportion of patients with larger ICH might be 
relevant, because such patients are less likely to undergo acute IADSA, and can be difficult to 
classify according to anatomical ICH location (could ref CHARTS). We did not include any 
patients with multiple acute haemorrhages, presumably because they were considered 
unlikely to have multiple macrovascular causes and thus did not undergo an IADSA at our 
centre. Despite these limitations, the demographic features of our study suggest that it is 
likely to be generalizable to the ICH population that in clinical practice is considered for 
investigation for an underlying macrovascular cause.  A further limitation is that we did not 
routinely undertake MRI in all included patients, and were therefore unable to investigate 
additional markers of cerebral SVD underlying ICH, such as cerebral microbleeds, dilated 
perivascular spaces or cerebral atrophy (23, 24). The use of standardised MRI prior to 
IADSA would have strengthened our study as it is better able to differentiate between the 
type of SVD (i.e. cerebral amyloid angiopathy or hypertensive arteriopathy), and is superior 
for the detection of other underlying causes for ICH (e.g cavernomas or mass lesions). 
However, the lack of MRI is unlikely to have compromised our ability to detect 
leukoaraiosis, the main SVD feature analysed in our study: a previous study (25) 
demonstrated that although MRI is more sensitive than CT in detecting subtle (Fazekas grade 
1) white matter lesions, MRI and CT have a high concordance in detecting clinically more 
relevant Fazekas grade 2 and 3 lesions, which we used as predictor in our analysis. Our 
choice of CT (which was available in all patients acutely at the time of haemorrhage) for 
assessment of white matter lesions is therefore very unlikely to have led to a significant 
underestimation of moderate- severe (Fazekas grade ≥2) small vessel disease. Furthermore, 
our (unpublished) internal inter-rater reliability is moderate to good for the identification of 
Fazekas 2/3 in ICH populations (Kappa = 0.60), and we were careful to exclude 
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perihaematomal oedema as a potential mimic of small vessel disease by assessing hemisphere 
contralateral to the ICH. We did not encounter any cases of transependymal oedema due to 
acute hydrocephalus, likely due to the selection bias of our patients where we only included 
those with IADSA, an intervention unlikely to be undertaken in such patients. By contrast, 
the poor sensitivity and specificity (especially with regards to differentiating enlarged 
perivascular spaces) of identifying lacunar infarction on CT remains a limitation.  
Conclusion 
In summary, we show, in a younger acute ICH population (median age 49 years) at risk of 
having an underlying macrovascular cause, the identification of SVD (moderately severe 
leukoaraiosis or lacunar infarction on CT), in combination with CTA and pre-ICH 
hypertension ICH, can predict which ICH patients have a low yield of an intracranial 
macrovascular cause. If externally validated, our algorithm has potential to more effectively 
target invasive IADSA towards patients with the highest potential diagnostic yield, avoiding 
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Table 1: Characteristics of the patients in the study 
Variable Entire cohort (n=173) 
Age, years, median (IQR) [Range] 49 (40 to 59) [18 to 86] 
Gender, Female n (%) 80 (46) 
Pre ICH HTN n (%) 52 (30) 
CTA to IADSA, Days, median (IQR) 2 (1 to 11) 
Abnormal CTA, n (%) 71 (41) 
Confluent leukoaraiosis on CT, n (%)  41 (24) 
Lacunar infarcts on CT, n (%) 13 (8) 
Any SVD on CT , n (%) 47 (27) 
Location of ICH: Cerebellar, n (%) 21 (12) 
Location of ICH: Deep perforator territory, n 
(%)* 
60 (35) 
Location of ICH: Pure intraventricular, n (%) 9 (5) 
Location of ICH: Lobar, n (%) 83 (48) 
Footnote: HTN –hypertension. ICH intracerebral haemorrhage, CTA –computed tomography 




Table 2: Univariable predictors of presence of a macrovascular cause on IADSA 
Predictor variable 
 
OR (95% CI) 
 
ROC AUC (95% 
CI) 
CTA positive* for vascular malformation 57.5 (21.9 to 150.5) 0.87 (0.82 to 0.92) 
ICH location   0.66 (0.59 to 0.74) 
 deep perforator territory ** 1 (ref)  
 cerebellar 4.4 (1.5 to 12.5)  
 pure intraventricular 6.6 (1.5 to 29.7)  
 lobar 4.1 (2.0 to 8.5)  
Absence of confluent SVD on CT 3.2 (1.5 to 6.7) 0.61 (0.54 to 0.67) 
No pre-ICH hypertension 2.4 (1.2 to 4.7) 0.59 (0.52 to 0.65) 
Age <45 years  1.3 (0.7 to 2.4) 0.53 (0.46 to 0.61) 
Footnote: IADSA –intraarterial digital subtraction angiography, ICH intracerebral 
haemorrhage, CTA Computed tomography angiography, SVD small vessel disease. OR –
odds ratio ROC –receiver operator curve, AUC –area under the curve  
* “Positive includes both “definite or possible” suspicion for a macrovascular cause by 
neuroradiological expert consensus 




Table 3: Yield of intracranial macrovascular causes from the optimised model compared to the 





of patients with a 
macrovascular cause  
for each combination 
of predictors in our 




proportion of patients 
with a macrovascular 
cause for each 
combination of 
predictors, % 
CTA result SVD on CT  HTN  
Positive No No 
95.3% (84.2 to 99.4) 
[41/43] 
95.8% 
Positive No Yes 
85.7% (57.2 to 98.2) 
[12/14] 
86.4% 
Positive Yes No 
80.0% (44.4 to 97.4) 
[8/10] 
83.7% 
Positive Yes Yes 
75.0% (19.4 to 99.4) 
[3/4] 
59.0% 
Negative No No 
23.1% (12.5 to 36.8) 
[12/52] 
22.1% 
Negative No Yes 
5.9%(0.1 to 28.7) 
[1/17] 
7.3% 
Negative Yes No 
6.3 % (0.2 to 30.2) 
[1/16] 
6.1% 






Footnote: CTA Computed tomography angiography, HTN hypertension, SVD. Small vessel 
disease. “Positive” includes CTA showing a “definite” or “possible” macrovascular cause; 




Figure legends and titles 
 
Figure 1 
Title: Flow chart for study. 
Footnote: IADSA –intra arterial digital subtraction angiography, ICH intracerebral 
hemorrhage, CTA –computed tomography angiography, AVM – arteriovenous malformation 
Figure 2 
Title: Optimised model ROC curve with Abnormal CTA, No pre stroke hypertension and no 
moderate to severe SVD on CT used as predictors of macrovascular cause.  
Figure 3 
Title: Suggested diagnostic algorithm  
Footnote: CTA –computed tomography angiogram, HTN -known pre ICH hypertension, 
WMH-white matter hyperintesities, IADSA –intra arterial digital subtraction angiography. 
“Positive” includes patients where the acute CTA shows a “definite” or “possible” 
macrovascular cause; “negative” CTA denotes those with no suspicion of a vascular 
malformation. 
 
 
